Evidence map›Paper›PMID 40234955›Full record

ArticleBreast cancer research : BCR2025

Central and peripheral adiposity and premenopausal breast cancer risk: a pooled analysis of 440,179 women.

Minouk J Schoemaker, Taylor Ellington, Hazel B Nichols, Lauren B Wright, Michael E Jones, Katie M O'Brien, Clarice R Weinberg, Hans-Olov Adami, Laura Baglietto, Kimberly A Bertrand and 21 more

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Minouk J Schoemaker *Real World Solutions, IQVIA, Amsterdam, The Netherlands.
Taylor Ellington *Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, McGavran Greenberg Building 2104F, Campus Box CB#7435, Chapel Hill, NC, 27599, USA.
Hazel B NicholsDepartment of Epidemiology, University of North Carolina Gillings School of Global Public Health, McGavran Greenberg Building 2104F, Campus Box CB#7435, Chapel Hill, NC, 27599, USA. Hazel.nichols@unc.edu.
Lauren B WrightEpidemiology and Cancer Statistics Group, University of York, York, UK.
Michael E JonesDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Katie M O'BrienEpidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, USA.
Clarice R WeinbergBiostatistics Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, USA.
Hans-Olov AdamiClinical Effectiveness Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
Laura BagliettoDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Kimberly A BertrandSlone Epidemiology Center at Boston University, Boston, USA.
Yu ChenPopulation Health, Epidemiology, NYU Grossman School of Medicine, New York, USA.
Jessica Clague DeHartSchool of Community and Global Health, Claremont Graduate University, Claremont, USA.
A Heather EliassenDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.
Graham G GilesCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Serena C HoughtonDepartment of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, USA.
Victoria A KirshOntario Institute for Cancer Research, Toronto, ON, Canada.
Roger L MilneCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Julie R PalmerSlone Epidemiology Center at Boston University, Boston, USA.
Hannah Lui ParkDepartments of Pathology and Epidemiology, University of California, Irvine, USA.
Thomas E RohanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Gianluca SeveriUniversité Paris-Saclay, UVSQ, Inserm, CESP U1018, "Exposome and Heredity" Team, Gustave Roussy, Villejuif, France.
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, USA.
Rulla M TamimiDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
Lars J VattenFaculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Elisabete WeiderpassInternational Agency for Research on Cancer (IARC)/ World Health Organization (WHO), Lyon, France.
Walter C WillettDepartment of Nutrition, Harvard T.H. Chan School of Public Health, Boston, USA.
Anne Zeleniuch-JacquottePopulation Health, Epidemiology, NYU Grossman School of Medicine, New York, USA.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, USA.
Dale P Sandler *Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, USA.
Anthony J Swerdlow *Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Premenopausal Breast Cancer Collaborative Group

Funding

A Follow-up Study for Causes of Cancer in Black WomenU01CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Kimberly A. Bertrand, Yvette C Cozier · 2017 to 2026
$24.0M
Cancer Control Education ProgramT32CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa B Gilkey, Melissa A. Troester · 2017 to 2026
$3.7M
Breast Cancer Research Foundation BCRF-23-140NCI NIH HHS T32 CA057726NCI NIH HHS U01 CA164974Susan G. Komen SAC220228World Health Organization 001
6 · The paper itself

Abstract

backgroundAmong premenopausal women, higher body mass index (BMI) is associated with lower breast cancer risk, although the underlying mechanisms are unclear. Investigating adiposity distribution may help clarify impacts on breast cancer risk. This study was initiated to investigate associations of central and peripheral adiposity with premenopausal breast cancer risk overall and by other risk factors and breast cancer characteristics.

methodsWe used individual-level data from 14 prospective cohort studies to estimate hazard ratios (HRs) for premenopausal breast cancer using Cox proportional hazards regression. Analyses included 440,179 women followed for a median of 7.5 years (interquartile range: 4.0-11.3) between 1976 and 2017, with 6,779 incident premenopausal breast cancers.

resultsAll central adiposity measures were inversely associated with breast cancer risk overall when not controlling for BMI (e.g. for waist circumference, HR per 10 cm increase: 0.92, 95% confidence interval (CI): 0.90-0.94) whereas in models adjusting for BMI, these measures were no longer associated with risk (e.g. for waist circumference: HR 0.99, 95% CI: 0.95-1.03). This finding was consistent across age categories, with some evidence that BMI-adjusted associations differed by breast cancer subtype. Inverse associations for in situ breast cancer were observed with waist-to-height and waist-to-hip ratios and a positive association was observed for oestrogen-receptor-positive breast cancer with hip circumference (HR per 10 cm increase: 1.08, 95% CI: 1.10-1.14). For luminal B, HER2-positive breast cancer, we observed an inverse association with hip circumference (HR per 10 cm: 0.84, 95% CI: 0.71-0.98), but positive associations with waist circumference (HR per 10 cm: 1.18, 95% CI: 1.03-1.36), waist-to-hip ratio (HR per 0.1 units: 1.29, 95% CI: 1.15-1.45) and waist-to height ratio (HR per 0.1 units: 1.46, 95% CI: 1.17-1.84).

conclusionsOur analyses did not support an association between central adiposity and overall premenopausal breast cancer risk after adjustment for BMI. However, our findings suggest associations might differ by breast cancer hormone receptor and intrinsic subtypes.

Indexed as

AdiposityBreast NeoplasmsObesity, AbdominalPremenopauseAdultBody Mass IndexFemaleHumansMiddle AgedProportional Hazards ModelsProspective StudiesReceptors, EstrogenRisk FactorsWaist CircumferenceReceptors, EstrogenAdiposityBreast cancerCohort study

Identifiers

PMID40234955
PMCPMC12001638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.